购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空

Anti-DLL4 Antibody (6A800)

Rating icon 还可以
产品编号 TMAY-00398

Anti-DLL4 Antibody (6A800) 是一种 Mouse 抗体,靶向 DLL4。Anti-DLL4 Antibody (6A800) 可用于 ELISA,ELISA(Cap)。

Anti-DLL4 Antibody (6A800)

Anti-DLL4 Antibody (6A800)

Rating icon 还可以
产品编号 TMAY-00398

Anti-DLL4 Antibody (6A800) 是一种 Mouse 抗体,靶向 DLL4。Anti-DLL4 Antibody (6A800) 可用于 ELISA,ELISA(Cap)。

TargetMol
产品信息正在更新中,如果您想购买,请点击大包装&定制按钮.
大包装 & 定制
实验操作小课堂
常见问题解答
查看更多
联系我们获取更多批次信息
资源下载

产品介绍

生物活性
产品描述
Anti-DLL4 Antibody (6A800) is a Mouse antibody targeting DLL4. Anti-DLL4 Antibody (6A800) can be used in ELISA,ELISA(Cap).
Ig Type
Monoclonal Mouse IgG1
克隆号
6A800
交叉反应
Human
应用
ELISA,ELISA(Cap)
推荐剂量
ELISA: 1:1000-1:2000; ELISA(Cap): 1:250-1:2000
抗体种类
Monoclonal
宿主来源Mouse
构建方式This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human DLL4 / Delta4 extracellular domain (rh DLL4; TMPY-01321; NP_061947.1; Met 1-Pro 524). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.
纯化方式Protein A
性状Liquid
缓冲液0.2 μm filtered solution in PBS with 10% Trehalose, 0.02% Tween 80, pH7.0
研究背景Delta-like protein 4 (DLL4, Delta4), a type I membrane-bound Notch ligand, is one of five known Notch ligands in mammals and interacts predominantly with Notch 1, which has a key role in vascular development. Recent studies yield substantial insights into the role of DLL4 in angiogenesis. DLL4 is induced by vascular endothelial growth factor (VEGF) and acts downstream of VEGF as a 'brake' on VEGF-induced vessel growth, forming an autoregulatory negative feedback loop inactivating VEGF. DLL4 is downstream of VEGF signaling and its activation triggers a negative feedback that restrains the effects of VEGF. Attenuation of DLL4/Notch signaling results in chaotic vascular network with excessive branching and sprouting. DLL4 is widely distributed in tissues other than vessels including many malignancies. Furthermore, the molecule is internalized on binding its receptor and often transported to the nucleus. In pathological conditions, such as cancer, DLL4 is up-regulated strongly in the tumour vasculature. Blockade of DLL4-mediated Notch signaling strikingly increases nonproductive angiogenesis, but significantly inhibits tumor growth in preclinical mouse models. In preclinical studies, blocking of DLL4/Notch signaling is associated with a paradoxical increase in tumor vessel density, yet causes marked growth inhibition due to functionally defective vasculature. Thus, DLL4 blockade holds promise as an additional strategy for angiogenesis-based cancer therapy.
偶联与修饰
偶联
Unconjugated
抗原信息
免疫原
Recombinant Human DLL4 protein (TMPY-01321)
抗原种属
Human
研究领域
Cancer Drug Targets, Notch Pathway
存储&运输
储存方式Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free.
运输方式Shipping with blue ice.

SCI 文献

计算器

  • 稀释 计算器

评论列表

4个月前
5.0
Rating icon 很棒

评论内容

Related Tags: buy Anti-DLL4 Antibody (6A800) | purchase Anti-DLL4 Antibody (6A800) | Anti-DLL4 Antibody (6A800) cost | order Anti-DLL4 Antibody (6A800)